You are on Trendlyne India. Click here to go to United States website or make India as your default

MPS Pharma Ltd. BSE: 531686 | GSM

MPS Pharma Ltd. Live Share Price Today, Share Analysis and Chart

2.88 -0.15 (-4.95%)

New 52W Low today

3,250 BSE Volume

High volume today

BSE 07 Apr, 2025 3:31 PM (IST)

MPS Pharma Key Metrics

Default
All financials are in INR Cr and price data in INR
VIEW MORE
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Not Eligible
-
Expensive Valuation
7.2 / 100
Technically Moderately Bullish
60.3 / 100

MPS Pharma Ltd. Live Price Chart

Fetching data ...

MPS Pharma Stock Analysis

MPS Pharma stock analysis with key metrics, changes, and trends.

MPS Pharma MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue₹0.09 Cr302.02%positive

Annual Revenue rose 302.02%, in the last year to ₹0.09 Cr. Its sector's average revenue growth for the last fiscal year was 11.87%.

Annual Net Profit₹0.83 Cr20.88%positive

Annual Net Profit rose 20.88% in the last year to ₹0.83 Cr. Its sector's average net profit growth for the last fiscal year was 26.81%.

Price to Earning Ratio-6.38-negative

Price to Earning Ratio is -6.38, which is negative.

Stock Price₹2.88-10.28%negative

Stock Price fell 10.28% and underperformed its sector by 25.89% in the past year.

Quarterly Net profit₹0.17 Cr18.68%positive

Quarterly Net profit rose 18.68% YoY to ₹0.17 Cr. Its sector's average net profit growth YoY for the quarter was 20.25%.

Debt to Equity Ratio3.69-negative

Debt to Equity Ratio of 3.69 is higher than 1. This implies that company assets are financed through debt.

Return on Equity(ROE)-42.21 %-42.21%negative

Return on Equity(ROE) for the last financial year was -42.21%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding0.00 %0%neutral

Mutual Fund Holding remained the same in the last quarter at 0%.

Promoter Share Holding35.89 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 35.89%.

Interest Coverage Ratio-563.32-negative

Interest Coverage Ratio is -563.32, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Promoter Pledges16.04 %0%neutral

Promoter Pledges stayed the same in the last quarter at 16.04%.

VIEW LESS


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

Annual Report Mar-2024
Annual Report Mar-2023
Annual Report Mar-2022
Annual Report Mar-2021
Annual Report Mar-2020
Annual Report Mar-2019
Annual Report Mar-2018
Annual Report Mar-2017
Annual Report Mar-2016
Annual Report Mar-2015
Annual Report Mar-2014
Annual Report Mar-2013
Annual Report Mar-2011

MPS Pharma Ltd. - Company Profile

What does MPS Pharma Ltd. do?

MPS Pharmaa in manufacturing, marketing, trading and export of Pharmaceutical Products.

Website: www.mpspharmaa.com

MPS Pharma Ltd. Management structure

All Gross Remunerations are in INR
Pooja Chuni
Company Secretary, Compliance Officer
4.8 Lac
2024-3-31
Gross Remuneration
Year
Mr. Manoj Bhatia
Chief Financial Officer
4.62 Lac
2024-3-31
Gross Remuneration
Year

MPS Pharma Ltd. Board of directors

All Gross Remunerations are in INR
Pooja Chuni
Company Sec. & Compli. Officer
4.8 Lac
2024
Gross Remuneration
Year
Peeyush Kumar Aggarwal
Managing Director
-
2024
Gross Remuneration
Year
Madhu Sharma
Independent Director
-
2024
Gross Remuneration
Year
Ram Niwas Sharma
Non Executive Director
-
2024
Gross Remuneration
Year
Ajay Sharma
Independent Director
-
2024
Gross Remuneration
Year

MPS Pharma Ltd. - company history

MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994. The Company was promoted in by the Jains along with a group of dedicated professionals. Presently, it is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality. During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level. In 2021-22, the Company became an Associate Company of Vikas Lifecare Limited as it had acquired 22.04% of the shareholding of the Company. As a result, on 20-06-2022, Vikas Lifecare Limited divested 04.53% shareholding of the Company; thereby its aggregate shareholding into the Company decreased to 17.51% and hence, the Company ceased to be an Associate of Vikas Lifecare Limited.

MPS Pharma Ltd. FAQ

How is MPS Pharma Ltd. today?
MPS Pharma Ltd. today is trading in the red, and is down by -4.95% at 2.88.
MPS Pharma Ltd. is currently trading down -4.95% on an intraday basis. In the past week the stock fell -4.95%. stock has been down -31.59% in the past quarter and fell -10.28% in the past year. You can view this in the overview section.